1Executive Summary1.1AI In Pharma – Market Attractiveness And Macro economic Landscape
2Table Of Contents
3List Of Tables
4List Of Figures
5Report Structure
6Market Characteristics
6.1General Market Definition
6.2Summary
6.3AI In Pharma Market Definition And Segmentations
6.4Market Segmentation By Technology
6.4.1Context-Aware Processing
6.4.2Natural Language Processing
6.4.3Querying Method
6.4.4Deep Learning
6.5Market Segmentation By Drug Type
6.5.1Small Molecule
6.5.2Large Molecules
6.6Market Segmentation By Application
6.6.1Diagnosis
6.6.2Clinical Trial Research
6.6.3Drug Discovery
6.6.4Research And Development
6.6.5Epidemic Prediction
7Major Market Trends
7.1Introduction Of Generative AI In Pharma To Improve Medical Consultations
7.2Use Of AI In Molecular Target Identification
7.3Integration Of AI In Drug Screening Process To Accelerate Drug Development
7.4Growing Investments To Develop New Product Solutions
7.5Strategic Partnerships And Collaborations Among Market Players
8AI In Pharma Market - Macro Economic Scenario
8.1COVID-19 Impact On The AI In Pharma Market
8.2Impact Of The War In Ukraine On The AI In Pharma Market
8.3Impact Of High Inflation On The AI In Pharma Market
9Global Market Size and Growth
9.1Market Size
9.2Historic Market Growth, 2017 – 2022, Value ($ Million)
9.2.1Market Drivers 2017 – 2022
9.2.2Market Restraints 2017 – 2022
9.3Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
9.3.1Market Drivers 2022 – 2027
9.3.2Market Restraints 2022 – 2027
10Global AI In Pharma Market Segmentation
10.1Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
10.2Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
10.3Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
11AI In Pharma Market, Regional and Country Analysis
11.1Global AI In Pharma Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
11.2Global AI In Pharma Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12Asia-Pacific Market
12.1Summary
12.1.1Market Overview
12.1.2Region Information
12.1.3Market Information
12.1.4Background Information
12.1.5Government Initiatives
12.1.6Regulations
12.1.7Regulatory Bodies
12.1.8Major Associations
12.1.9Taxes Levied
12.1.10Corporate Tax Structure
12.1.11Investments
12.1.12Major Companies
12.2Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.3Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.4Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.5Asia-Pacific AI In Pharma Market: Country Analysis
12.6China Market
12.7Summary
12.7.1Market Overview
12.7.2Country Information
12.7.3Market Information
12.7.4Background Information
12.7.5Government Initiatives
12.7.6Regulations
12.7.7Regulatory Bodies
12.7.8Major Associations
12.7.9Taxes Levied
12.7.10Corporate Tax Structure
12.7.11Investments
12.7.12Major Companies
12.8China AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.9China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.1China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.11India Market
12.12India AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.13India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.14India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.15Japan Market
12.16Japan AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.17Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.18Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.19Australia Market
12.2Australia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.21Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.22Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.23Indonesia Market
12.24Indonesia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.25Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.26Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.27South Korea Market
12.28South Korea AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.29South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.3South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13Western Europe Market
13.1Summary
13.1.1Market Overview
13.1.2Region Information
13.1.3Market Information
13.1.4Background Information
13.1.5Government Initiatives
13.1.6Regulations
13.1.7Regulatory Bodies
13.1.8Major Associations
13.1.9Taxes Levied
13.1.10Corporate Tax Structure
13.1.11Investments
13.1.12Major Companies
13.2Western Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.3Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.4Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.5Western Europe AI In Pharma Market: Country Analysis
13.6UK Market
13.7UK AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.8UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.9UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.1Germany Market
13.11Germany AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.12Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.13Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.14France Market
13.15France AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.16France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.17France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14Eastern Europe Market
14.1Summary
14.1.1Market Overview
14.1.2Region Information
14.1.3Market Information
14.1.4Background Information
14.1.5Government Initiatives
14.1.6Regulations
14.1.7Regulatory Bodies
14.1.8Major Associations
14.1.9Taxes Levied
14.1.10Corporate Tax Structure
14.1.11Investments
14.1.12Major Companies
14.2Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.3Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.4Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.5Eastern Europe AI In Pharma Market: Country Analysis
14.6Russia Market
14.7Russia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.8Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.9Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15North America Market
15.1Summary
15.1.1Market Overview
15.1.2Region Information
15.1.3Market Information
15.1.4Background Information
15.1.5Government Initiatives
15.1.6Regulations
15.1.7Regulatory Bodies
15.1.8Major Associations
15.1.9Taxes Levied
15.1.10Corporate Tax Structure
15.1.11Investments
15.1.12Major Companies
15.2North America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.3North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.4North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.5North America AI In Pharma Market: Country Analysis
15.6USA Market
15.7Summary
15.7.1Country Information
15.7.2Market Information
15.7.3Background Information
15.7.4Government Initiatives
15.7.5Regulations
15.7.6Regulatory Bodies
15.7.7Major Associations
15.7.8Taxes Levied
15.7.9Corporate Tax Structure
15.7.10Investments
15.7.11Major Companies
15.8USA AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.9USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.1USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16South America Market
16.1Summary
16.1.1Market Overview
16.1.2Region Information
16.1.3Market Information
16.1.4Background Information
16.1.5Government Initiatives
16.1.6Regulations
16.1.7Regulatory Bodies
16.1.8Major Associations
16.1.9Taxes Levied
16.1.10Corporate Tax Structure
16.1.11Investments
16.1.12Major Companies
16.2South America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.3South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.4South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.5South America AI In Pharma Market: Country Analysis
16.6Brazil Market
16.7Brazil AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.8Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.9Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17Middle East Market
17.1Summary
17.1.1Market Overview
17.1.2Region Information
17.1.3Market Information
17.1.4Background Information
17.1.5Government Initiatives
17.1.6Regulations
17.1.7Regulatory Bodies
17.1.8Major Associations
17.1.9Taxes Levied
17.1.10Corporate Tax Structure
17.1.11Investments
17.1.12Major Companies
17.2Middle East AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17.3Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17.4Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18Africa Market
18.1Summary
18.1.1Market Overview
18.1.2Region Information
18.1.3Market Information
18.1.4Background Information
18.1.5Government Initiatives
18.1.6Regulations
18.1.7Regulatory Bodies
18.1.8Major Associations
18.1.9Taxes Levied
18.1.10Corporate Tax Structure
18.1.11Investments
18.1.12Major Companies
18.2Africa AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18.3Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18.4Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
19Competitive Landscape And Company Profiles
19.1Company Profiles
19.2Concerto HealthAI
19.2.1Company Overview
19.2.2Products And Services
19.2.3Business Strategy
19.2.4Financial Overview
19.3Alphabet Inc.
19.3.1Company Overview
19.3.2Products And Services
19.3.3Business Strategy
19.3.4Financial Overview
19.4OWKIN
19.4.1Company Overview
19.4.2Products And Services
19.4.3Business Strategy
19.4.4Financial Overview
19.5Nvidia Corporation
19.5.1Company Overview
19.5.2Products And Services
19.5.3Business Strategy
19.5.4Financial Overview
19.6PathAI
19.6.1Company Overview
19.6.2Products And Services
19.6.3Business Strategy
19.6.4Financial Overview
20Key Mergers And Acquisitions
20.1BioNTech Acquired InstaDeep
20.2Recursion Pharmaceuticals Acquired Cyclica And Valence
20.3Telix Pharmaceuticals Acquired Dedicaid GmbH
20.4Envision Pharma Group Acquired OKRA.ai
20.5Bayer AG Acquired Blackford Analysis Ltd
20.6iBio Acquired Rubryc Therapeutics
20.7Genentech Acquired Prescient Design
20.8Nurosene Health Inc Acquired Netramark Incorporated
20.9X-Chem Acquired Glamorous AI
21Opportunities And Strategies
21.1Global AI In Pharma Market In 2027 – Countries Offering Most New Opportunities
21.2Global AI In Pharma Market In 2027 – Segments Offering Most New Opportunities
21.3Global AI In Pharma Market In 2027 – Growth Strategies
21.3.1Market Trend Based Strategies
21.3.2Competitor Strategies
22AI In Pharma Market, Conclusions And Recommendations
22.1Conclusions
22.2Recommendations
22.2.1Product
22.2.2Place
22.2.3Price
22.2.4Promotion
22.2.5People
23Appendix
23.1Geographies Covered
23.2Market Data Sources
23.3Research Methodology
23.4Currencies
23.5The Business Research Company
23.6Copyright and Disclaimer